These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23049949)

  • 1. Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction.
    Paulitschke V; Gruber S; Hofstätter E; Haudek-Prinz V; Klepeisz P; Schicher N; Jonak C; Petzelbauer P; Pehamberger H; Gerner C; Kunstfeld R
    PLoS One; 2012; 7(9):e46103. PubMed ID: 23049949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
    Ray DM; Akbiyik F; Phipps RP
    J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
    Aoun P; Watson DG; Simpkins JW
    Eur J Pharmacol; 2003 Jul; 472(1-2):65-71. PubMed ID: 12860474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
    Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
    Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
    Aoun P; Simpkins JW; Agarwal N
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15-Deoxy-Δ
    Yamamoto Y; Koma H; Yagami T
    Biol Pharm Bull; 2020; 43(1):153-157. PubMed ID: 31902920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
    Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
    J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of peroxisome proliferator-activated receptor gamma and its ligands on cytotrophoblast invasion in first trimester of pregnancy and mechanism thereof].
    Li SJ; Shang T; Li SY; Li QL
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):174-8. PubMed ID: 17425848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
    Nie M; Corbett L; Knox AJ; Pang L
    J Biol Chem; 2005 Jan; 280(4):2550-61. PubMed ID: 15531761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
    Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
    J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
    Coyle AT; Kinsella BT
    Biochem Pharmacol; 2006 Apr; 71(9):1308-23. PubMed ID: 16499875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
    Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
    Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.